Olio Labs is a biotechnology research company headquartered in South San Francisco, California, operating a discovery platform that connects human outcomes, target discovery, and target validation.
Subscribe to see Olio Labs’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Olio Labs is a biotech company headquartered in South San Francisco, United States. Its most recent funding round, Series A, raised $4.5M in March 2025. Xcout tracks 1 named person at Olio Labs, including David Tingley (CEO).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $4.5M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Olio Labs's closest competitors — see the full list of competitors and alternatives →
Rezo Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, that integrates proteomics, genetics, and structural biology for drug discovery and development.
Gordian Biotechnology is a biotechnology research company headquartered in South San Francisco, California. The company focuses on curing age-related diseases through in vivo target discovery and functional genomics platforms.
Aperture Therapeutics is a biotechnology research company founded in 2022 and headquartered in San Carlos, California. The company is building an innovative drug discovery platform that leverages patient genetic diversity and mechanistic insights.
Dualitas Therapeutics is a privately held biotechnology research company headquartered in South San Francisco, California, that utilizes its DualScreen Bispecific Discovery Engine for proximity engagers.
Standard Model Biomedicine is a biotechnology research company based in San Francisco, United States. The company is focused on developing a foundation model for human biology to advance biomedical research.
Variant Bio is a privately held biotechnology company founded in 2018 and headquartered in Seattle, Washington. The company aims to develop life-saving therapeutics by studying the genetic variations of human populations with exceptional health-related traits.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Olio Labs? Suggest a correction · Work at Olio Labs? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.